Vivos Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Vivos Therapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 14% to $13,801,000. The net income raised on -$13,583,000 and profit margin reached -98%. Total operating expenses were $24,946,000.
Profit Margin
| 2018 | 3.79M | -8.54M | -225.25% |
|---|---|---|---|
| 2019 | 11.39M | -10.89M | -95.6% |
| 2020 | 13.06M | -8.82M | -67.52% |
| 2021 | 16.88M | -20.29M | -120.18% |
| 2022 | 16.02M | -22.65M | -141.41% |
| 2023 | 13.80M | -13.58M | -98.42% |
VVOS Income Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 13.80M | 16.02M | 16.88M | 13.06M | 11.39M | 3.79M |
Cost of revenue | 5.53M | 6.00M | 4.28M | 2.65M | 2.73M | 1.08M |
Gross profit | 8.27M | 10.01M | 12.60M | 10.41M | 8.65M | 2.71M |
Operating exp. | ||||||
Research and development | 100K | 200K | 0 | 0 | 0 | 0 |
Selling and marketing | 2.46M | 5.34M | 5.55M | 2.31M | 2.31M | 1.16M |
Total operating expenses | 24.94M | 35.05M | 32.07M | 19.12M | 19.23M | 11.04M |
Operating income | -17.29M | -25.03M | -19.47M | -8.70M | -10.57M | -8.33M |
Other income (expenses), net | 3.71M | 1.18M | -817K | -16.87K | -177.08K | -102.97K |
Income before tax | -13.58M | -23.84M | -20.28M | -12.05M | -10.75M | -8.43M |
Income tax expense | 0 | -1.18M | 5K | -3.23M | 137.87K | 102.97K |
Net income | -13.58M | -22.65M | -20.29M | -8.82M | -10.89M | -8.54M |
Earnings per share | ||||||
Basic EPS | -11.14 | -24.62 | -23.89 | -12.11 | -14.97 | -18.49 |
Diluted EPS | -11.14 | -24.62 | -23.89 | -12.11 | -14.97 | -18.49 |
| Data source | Data source | Data source | Data source |